The IPO Window Is Selective: Liquidity, Lockups and Earnings Face the Same Test

The fourth quarter is producing enough new supply to make market plumbing relevant again, but not enough to support a simple “IPO boom” narrative. The more useful question is whether demand, liquidity and operating evidence can absorb new shares without turning every listing or secondary into a volatility event.

The supply signal is real, but narrow

Renaissance Capital’s October 2 week-ahead report identified two US biotech IPOs scheduled for the following week: TRex Bio (TRXB), with a planned $125 million raise, and Retension Pharmaceuticals (RTSN), with a planned $40 million raise. Those are reported planned terms, not completed transactions, and expected calendars can change. The same report said four lock-up periods were due to expire that week, adding potential secondary supply even as primary issuance remained light.^[1]

A separate market summary counted 251 US IPOs through October 8, versus 277 by the same point in 2025, a 9.39% year-over-year decline. That count is a useful scale check, but it should not be treated as a complete measure of capital formation or aftermarket quality.^[2]

The base case, then, is selective access: companies with credible demand, a clear use of proceeds and enough trading support can come to market, while the calendar remains sensitive to volatility and investor attention.

Liquidity is becoming a rulebook question

The SEC published an October 7 order concerning a temporary amendment to the national-market-system plan for extraordinary volatility in overnight trading. The filing addresses how the consolidated price is calculated for overnight protections.^[3] Separately, exchange filings in October addressed the resumption of trading after a Level 3 market-wide circuit breaker in the context of expanded trading hours.^[4]

These developments do not guarantee smoother trading. They show that the market’s operating hours and protection mechanisms are evolving at the same time that issuers are testing investor demand. For an IPO, that matters because the first weeks of trading are a price-discovery process: thinner liquidity, lock-up releases and longer trading windows can make the path from offer price to durable ownership more important than the first-day print.

The earnings cross-check: demand must become cash generation

The supplied growth hypothesis includes DDOG and SNOW alongside consumer and housing-sensitive names RH, WSM, LZB, LESL and TPX, plus ETH. The available transcript evidence supports parts of the thesis but not a blanket conclusion.

In a Datadog earnings-call block, management reported $4.8 billion in cash, cash equivalents and marketable securities, $335 million of operating cash flow and $289 million of free cash flow for the quarter, while also describing continued investment in hiring and long-term growth opportunities.^[5] That combination—demand investment alongside internally generated liquidity—is the kind of evidence public-market investors may reward when issuance is selective.

Snowflake’s reported call commentary was more explicit on expansion and capital allocation: 733 customers were spending more than $1 million on a trailing 12-month basis, up 27% year over year; 56 customers were above $10 million, up 56%; the company said it repurchased approximately 668,000 shares for $150 million in the quarter and had $1.1 billion remaining under its authorization.^[6] These figures support the “resilient demand plus capital discipline” side of the hypothesis, though they do not eliminate valuation, execution or competition risk.

The market snapshot on October 8 was mixed: SNOW closed at $343.40 after a 3.17% session move, DDOG at $273.80 after a 0.91% move, while ETH closed at $23.48 after a 4.16% decline.^[7] The snapshot is not a causal explanation, and it is incomplete for names that did not appear in the returned market-wide rows. It does, however, reinforce the central point: operating evidence and liquidity conditions can diverge quickly across a broad scope.

A practical checklist for the next issuance wave

What would confirm—or weaken—the hypothesis

The hypothesis would gain support if upcoming issuers price successfully without immediate reliance on speculative momentum; lock-up releases are absorbed with orderly volume; and DDOG, SNOW and the consumer names show demand translating into margins or cash flow. Buybacks can support per-share supply-demand balance, but they are not a substitute for durable operating growth.

It would weaken if the calendar fills mainly with small, fragile offerings; if secondary supply overwhelms daily liquidity; if customer expansion slows while spending remains elevated; or if extended-hours trading produces repeated dislocations. In that scenario, the IPO count could rise while the quality of public-market access deteriorates.

What to watch next

1. The next confirmed pricing and listing notices. Treat expected dates as provisional until an issuer or authoritative filing confirms the event.
2. Lock-up releases in newly public companies. Compare potential shares becoming available with normal trading volume rather than reading the date in isolation.
3. SNOW and DDOG operating follow-through. Track customer expansion, free cash flow, investment intensity and buyback activity against the growth narrative.
4. RH, WSM, LZB, LESL and TPX demand signals. Consumer and housing-sensitive demand can test whether the earnings thesis extends beyond enterprise software.
5. Overnight-market protections and halt mechanics. The rules are changing; the practical question is whether price discovery remains orderly as trading hours expand.

This is research, not a forecast or trading advice. The evidence currently favors a selective reopening in which liquidity quality and operating proof matter more than the raw number of new listings.